Remove Drug Development Remove healthcare technology Remove Strategy
article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development. Learn more at koneksahealth.com.

article thumbnail

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today! In 2011, the Jeopardy!-winning

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

Health Policy: The impact of healthcare policy on patient outcomes and access to care. The future of healthcare financing and payment models. The role of government and private sector in shaping the future of healthcare. Investment Strategy: The investment landscape for healthcare startups and emerging technologies.

article thumbnail

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

article thumbnail

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Lloyd Price

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!